[HTML][HTML] Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development

MH Abdul-Aziz, J Lipman, JW Mouton… - … in respiratory and …, 2015 - thieme-connect.com
The recent surge in multidrug-resistant pathogens combined with the diminishing antibiotic
pipeline has created a growing need to optimize the use of our existing antibiotic …

Therapeutic drug monitoring of antibiotics: defining the therapeutic range

MH Abdul–Aziz, K Brady, MO Cotta… - Therapeutic drug …, 2022 - journals.lww.com
Purpose: In the present narrative review, the authors aimed to discuss the relationship
between the pharmacokinetic/pharmacodynamic (PK/PD) of antibiotics and clinical …

The importance of bactericidal drugs: future directions in infectious disease

RW Finberg, RC Moellering, FP Tally… - Clinical infectious …, 2004 - academic.oup.com
Background. Although a considerable amount of research has gone into the study of the role
of bactericidal versus bacteriostatic antimicrobial agents in the treatment of different …

Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia

G Garrabou, A Soriano, S López… - Antimicrobial agents …, 2007 - Am Soc Microbiol
The objective of the present study was to determine the mitochondrial toxicity mechanisms of
linezolid-related hyperlactatemia. Five patients on a long-term schedule of linezolid …

Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and …

SA Helmy - Therapeutic drug monitoring, 2013 - journals.lww.com
Background: Linezolid may be administered in combination with norfloxacin, gatifloxacin,
levofloxacin, moxifloxacin, and tinidazole for the treatment of various infections, such as …

Linezolid for endocarditis: a case series of 14 patients

C Tascini, MG Bongiorni, R Doria… - Journal of …, 2011 - academic.oup.com
Sir, Linezolid is an antibiotic with bacteriostatic activity against Gram-positive
microorganisms licensed for complicated skin and soft tissue infections and pneumonia, but …

Association of pharmacokinetic and pharmacodynamic aspects of linezolid with infection outcome

KZ Vardakas, I Kioumis, ME Falagas - Current drug metabolism, 2009 - ingentaconnect.com
Linezolid is the first antibiotic of a new class (oxazolidinones). It inhibits protein synthesis by
binding to the bacterial 23S ribosomal RNA of the 50S subunit, thus blocking the formation …

Antibiotic dosing for multidrug-resistant pathogen pneumonia

MH Abdul-Aziz, J Lipman… - Current Opinion in …, 2017 - journals.lww.com
Conventional antibiotic dosing increases the likelihood of therapeutic failure in critically ill
patients with nosocomial pneumonia. Alternative dosing strategies, which exploit the …

Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased …

C Cabellos, C Garrigós, F Taberner, E Force… - Journal of Infection and …, 2014 - Elsevier
Background To evaluate in vitro and in vivo efficacies of linezolid, vancomycin, and the
combination of linezolid and rifampicin against two Staphylococcus aureus strains with …

Тенденции в распространении антибиотико-резистентности среди грамположительных микроорганизмов и перспективы ее преодоления

СВ Сидоренко - Клиническая фармакология и терапия, 2006 - elibrary.ru
десятков тысяч известных науке видов бактерий и еще большего количества
неизвестных роль в патологии человека доказана для нескольких сотен. Но при этом …